Literature DB >> 2912979

Ganglioside-specific binding protein on rat brain membranes.

M Tiemeyer1, Y Yasuda, R L Schnaar.   

Abstract

A derivative of ganglioside GT1b (IV3NeuAc,II3(NeuAc)2-GgOse4) with an active ester in its lipid portion was synthesized and covalently attached to bovine serum albumin (BSA). The conjugate, having four GT1b molecules per albumin molecule [GT1b)4BSA) was radioiodinated and used to probe rat brain membranes for ganglioside binding proteins. A ganglioside-specific, high affinity (KD = 2-4 nM), saturable (Bmax = 13-20 pmol/mg membrane protein) binding site for 125I-(GT1b)4BSA was demonstrated on detergent-solubilized rat brain membranes adsorbed to filters. 125I-(GT1b)4BSA binding was tissue-specific (more than 35-fold greater to brain than to liver membranes) and was nearly eliminated by pretreatment of brain membrane-adsorbed filters with trypsin (1 microgram/ml). Underivatized gangliosides added as mixed detergent-lipid micelles blocked 125I-(GT1b)4BSA binding to brain membranes; structurally related GQ1b, GT1b, and GD1b were the most potent (half-maximal inhibition at 70-110 nM), while half-maximal inhibition by other gangliosides (GD3, GD1a, GM3, GM2, and GM1) required 5-20-fold higher concentrations. Other sphingolipids, neutral glycosphingolipids, and glycoproteins were poor inhibitors, and treatment of (GT1b)4BSA with neuraminidase attenuated its binding. Although most phospholipids were noninhibitory, phosphatidylinositol and phosphatidylglycerol inhibited half-maximally at 400-600 nM. However, inhibition of 125I-(GT1b)4BSA binding by gangliosides was competitive and reversible while that by phosphatidylinositol and phosphatidylglycerol was not. Ganglioside-protein conjugate binding reveals ganglioside-specific brain membrane receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912979

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  [Tumor lectinology--status and perspectives of clinical application].

Authors:  H J Gabius; S Gabius
Journal:  Naturwissenschaften       Date:  1990-11

2.  Glycopeptide-albumin derivative: it preparation and histochemical ligand properties.

Authors:  H J Gabius; U Brinck; T Lüsebrink; T Ciesiolka; S Gabius
Journal:  Histochem J       Date:  1991-07

Review 3.  Sweet complementarity: the functional pairing of glycans with lectins.

Authors:  H-J Gabius; J C Manning; J Kopitz; S André; H Kaltner
Journal:  Cell Mol Life Sci       Date:  2016-03-08       Impact factor: 9.261

Review 4.  Polyacrylamide-based glycoconjugates as tools in glycobiology.

Authors:  N V Bovin
Journal:  Glycoconj J       Date:  1998-05       Impact factor: 2.916

5.  Binding and transport of gangliosides by prosaposin.

Authors:  M Hiraiwa; S Soeda; Y Kishimoto; J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

6.  The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin.

Authors:  L K Needham; R L Schnaar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

7.  Carbohydrate recognition in the peripheral nervous system: a calcium-dependent membrane binding site for HNK-1 reactive glycolipids potentially involved in Schwann cell adhesion.

Authors:  L K Needham; R L Schnaar
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

8.  Hemolysis of human erythrocytes is a new bioactivity of gangliosides.

Authors:  K Horikawa; H Nakakuma; S Nagakura; M Kawakita; T Kagimoto; M Iwamori; Y Nagai; T Abe; K Takatsuki
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

Review 9.  Complex carbohydrates in drug development.

Authors:  R L Schnaar
Journal:  Adv Pharmacol       Date:  1992
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.